Published December 22, 2025 | Version v1
Dataset Open

Supplementary Table S1. Anonymized dataset used for the article- Apoptosis of Mesothelial Cells Is Associated with the Pattern of Peritoneal Metastases in Ovarian Cancer

Authors/Creators

  • 1. Department of Pathology, Clinical Hospital of Obstetrics and Gynecology, Poznan University of Medical Sci-ences, Polna 33 Str., 60-535 Poznan, Poland
  • 2. Poznan Medical University of Prince Mieszko I, Faculty of Medical Sciences. 55 Bulgarska Str., 60-320 Poznan, Poland
  • 3. The Student Scientific Society of Poznan University of Medical Sciences; 5 Rokietnicka Str., 60-806 Poznan, Poland
  • 4. Student's Research Group of Gynaecological Oncology, Poznan University of Medical Sciences, Polna 33 Str., 60-535 Poznan, Poland
  • 5. Division of Gynaecological Oncology, Department of Gynaecology, Poznan University of Medical Sciences, Poznan, Poland, 33 Polna Str., 60-535 Poznan, Poland
  • 6. Department of Professionally Oriented Disciplines, Kharkiv International Medical University, 38 Molochna Str, 61-100 Kharkiv, Ukraine
  • 7. Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, 60-781, Poland
  • 8. Department of Gynaecological Oncology, Institute of Oncology, University of Medical Sciences, 82/84 Szamar-zewskiego Str., 60-569 Poznan, Poland

Description

This dataset serves as supplementary material for the research article titled: Apoptosis of Mesothelial Cells Is Associated with the Pattern  of Peritoneal Metastases in Ovarian Cancer.

Abstract: Background/Objectives: Peritoneal carcinomatosis is the leading cause of death in advanced ovarian cancer (AOC). Mesothelial cells lining the peritoneum modulate tumor implantation, yet the role of their apoptosis in metastasis development remains unclear. This study investigated the relationship between mesothelial cell apoptosis and metastatic spread in ovarian cancer (OC). Methods: The study included 26 patients with AOC, 11 with early-stage OC (EOC), and 13 healthy controls. Apoptotic activity in parietal peritoneal wall and omental mesothelial cells was assessed using the TUNEL technique. Metastases were classified as pushing or infiltrating. Associations with the peritoneal cancer index (PCI), BRCA mutation, and homologous recombination deficiency (HRD) status were analyzed. Results: Mesothelial cells adjacent to AOC metastases exhibited significantly higher apoptotic activity compared to controls (P < 0.05). Apoptosis was greater near infiltrating metastases than near pushing ones in both parietal (P < 0.01) and omental (P = 0.04) sites. The infiltration pattern was consistent between omental and parietal metastases (R = 0.588, P < 0.01). No significant differences in apoptosis were found, between EOC and healthy controls, or in tumor and stromal cells between invasion types. Mesothelial apoptosis was independent of PCI, BRCA mutation, and HRD status. Conclusions: Our study suggests that mesothelial cell apoptosis may be associated with peritoneal spread in OC. Mesothelial cell apoptosis is more pronounced near infiltrative-type lesions, independent of BRCA/HRD status. These findings highlight mesothelial apoptosis as a relevant process in peritoneal dissemination. Further studies are needed to clarify its role in ovarian cancer progression.

The provided Excel file contains characteristics of tissue samples obtained from: 26 patients with advanced- stage ovarian cancer (FIGO IIIC) [AOC],11 patients with early-stage ovarian cancer (FIGO IC) [AOC] and a control group consisting of 13 women who underwent surgery for benign gynecological conditions, mostly due to menorrhagia [healthy controls].

Files

Files (17.2 kB)